pharmaceutical-industry

Documents about pharmaceutical-industry

• The Australian Pharmaceutical Industry and its Global Context#1026059Victoria University Research Repository (VURR)
• Japanese Pharmaceutical Industry#68678J-STAGE (Japan)
• Ethics and the Pharmaceutical Industry#765026PhilArchive
• Innovation and industry structure in the biomedical industry: some preliminary results#1026052Victoria University Research Repository (VURR)
• Implications of the Business Strategies of Pharmaceutical Companies for Industry Developments in Australia#1026056Victoria University Research Repository (VURR)
• Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry#465590OpenAlex
• The Role of Pharmaceutical Alliances#1026055Victoria University Research Repository (VURR)
• USES AND IMPACT OF 3D PRINTING TECHNOLOGY#26370DataCite
• USES AND IMPACT OF 3D PRINTING TECHNOLOGY#26371DataCite
• Aspects of the Pharmaceutical Business Model: Implications for Australia#1026053Victoria University Research Repository (VURR)
• Overdosed America#466069Open Library
• In Pursuit of Profitability and Effectiveness in the Global Pharmaceutical Industry: Comments on Professor Walker's Four Challenges#493931Digital Repository @ Maurer Law
• Development Paths for Australian Biomedical Firms#1026054Victoria University Research Repository (VURR)
• The World Health Organization and the Pharmaceutical Industry#270991WIPO
• Patents and licensing in pharmaceutical industry#271032WIPO
• Nasty, Brutish, and Short: Embeddedness Failure in the Pharmaceutical Industry#461151MIT Open Scholarship
• Alliance Opportunities for Aus Biotech#1026047Victoria University Research Repository (VURR)
• Product management and performance appraisal systems in the Canadian pharmaceutical industry#1020664Spectrum: Concordia University Research Repository
• Intellectual Property and the Pharmaceutical Industry: A Moral Crossroads Between Health and Property#116515PhilArchive
• [WHO list of international comparator products]#313889WHO IRIS
• The Effects of TRIPs on developing countries with particular emphasiss on the pharmaceutical Industry#956612SU+ Digital Repository
• WHO Expert Committee on Specifications for Pharmaceutical Preparations: fifty-seventh report#194078WHO IRIS
• Insights into flow and continuous systems in pharmaceutical manufacturing: challenges and opportunities#450725ULRR
• Solid solutions of pharmaceutical compounds: a new crystal engineering strategy for drug formulations#413328ULRR
• The rising Chinese pharmaceutical industry: local champions vs global players#271029WIPO
• Healthcare systems, the State, and innovation in the pharmaceutical industry#271033WIPO
• The Effects of False Claims Act Whistleblowers on the Pharmaceutical Industry#485775Harvard DASH
• Tono-Bungay#24960Project Gutenberg
• Impacts of Cyber Security and Supply Chain Risk on Digital Operations: Evidence from the Pharmaceutical Industry#111380PhilArchive
• A View From Inside Industry: A Response to Professor Walker's Challenges#493934Digital Repository @ Maurer Law
• IPRs, technological and industrial development and growth: the case of the pharmaceutical industry#271012WIPO
• The impact of the pharmaceutical industry on the innovation performance of European countries#271035WIPO
• DBM-1152A Inhalation Solution in Chinese Healthy Subjects#843733ClinicalTrials.gov
• The Biomedical Sectors in Australia and Canada: A Comparative Analysis#1026051Victoria University Research Repository (VURR)
• The pharmaceutical industry's multifaceted role in neglected tropical disease control: from market failure to global health innovation.#182582NCBI PubMed Central
• The relationship of industry structure to open innovation: cooperative value creation in pharmaceutical consortia#621297WIPO
• The Biomedical Sectors in Australia and Canada: Comparative Policy Analysis#1026048Victoria University Research Repository (VURR)
• A Phase 2 Trial of JKN24011 in COPD#800634ClinicalTrials.gov
• The Quality Use of Medicines: Serving Health and Economic Objectives?*#1026008Victoria University Research Repository (VURR)
• R&D Price Inflation, Real BERD and Innovation: Pharmaceuticals, OECD 1980-2000#1026058Victoria University Research Repository (VURR)
• Natural products in drug discovery: advances and opportunities#10468OpenAlex
• What are the most promising conduits for foreign knowledge inflows? innovation networks in the Chinese pharmaceutical industry#163630WIPO
• Open PHACTS: semantic interoperability for drug discovery#421592OpenAlex
• A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD#810770ClinicalTrials.gov
• An Analysis of The Biomedical Sectors in Australia and Canada in a National Innovation Systems Context#1026050Victoria University Research Repository (VURR)
• The Policy of Functional Integration of the Product Planning Team as a Strategy for the Development of the Pharmaceutical Industry in Palestine#117422PhilArchive
• An Exploratory study of the constraints to growth of micro and small retail pharmaceutical enterprises in Nairobi, Kenya#956369SU+ Digital Repository
• Role of marine bioprospecting contracts in developing access and benefit sharing mechanism for marine traditional knowledge holders in the pharmaceutical industry#429120WIPO
• PLA-b-SMA as an amphiphilic diblock copolymer for encapsulation of lipophilic cargo#252006SUNScholar
• Harnessing artificial intelligence for the next generation of 3D printed medicines#686506OpenAlex